25 of the Best Hematologist Oncologists Near Me in richmond, CA

Ashutosh Lal is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Lal is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Thalassemia, Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Elliott Vichinsky is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Vichinsky is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.

Mark Walters is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Walters is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Hemoglobinopathy, Congenital Hemolytic Anemia, Sickle Cell Disease, Hemolytic Anemia, and Bone Marrow Transplant.

Sylvia Singer is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Singer is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Thalassemia, Beta Thalassemia, Hemoglobinopathy, Congenital Hemolytic Anemia, and Splenectomy.

Carolyn Hoppe is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Hoppe is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

James Feusner is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Feusner is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Hepatoblastoma, Acute Myeloid Leukemia (AML), and Leukemia.

Dr. Wei Ai is a blood cancer specialist who cares for adults with conditions such as Hodgkin's lymphoma and non-Hodgkin's lymphoma, including cutaneous lymphomas, which primarily involve the skin. She also sees patients needing blood and bone marrow transplantation. In her research, Ai focuses on novel approaches to lymphoma treatment, especially targeted agents for T-cell lymphomas. Her studies often lead to clinical trials of new therapies that target cancer at the molecular level. Ai earned a doctoral degree in microbiology and immunology as well as her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine at UCSF, followed by fellowship training in medical oncology at Stanford. Dr. Ai is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Mycosis Fungoides, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ai is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ai is currently accepting new patients.

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Olin is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Olin is currently accepting new patients.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Prostatectomy, and Liver Embolization. Dr. Munster is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Munster is currently accepting new patients.

Dyaneshbapu Ravindran is a Hematologist Oncology specialist and an Oncologist practicing medicine in Vallejo, California. Dr. Ravindran is highly rated in 73 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. Dr. Ravindran is currently accepting new patients.

Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system. Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma. After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology. Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists. Dr. Chung is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Chung is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Internal Medicine. Dr. Chung is currently accepting new patients.

Christopher Dvorak is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Dvorak is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Hepatic Venoocclusive Disease with Immunodeficiency, Graft Versus Host Disease (GvHD), Primary Immunodeficiency (PID), Bone Marrow Transplant, and Splenectomy.

Dr. James Rubenstein is a hematologist-oncologist, or a specialist in blood disorders. He has particular expertise in treating patients with neurologic complications from cancer, including patients with non-Hodgkin's lymphoma involving the brain (called central nervous system lymphoma). He also specializes in patients with cancer that has spread to the brain from other parts of the body. In his research, Rubenstein investigates immunologic tools to improve tumor response to chemotherapy and radiation treatment, and to minimize toxicity from treatment. He is also interested in developing tumor biomarkers to diagnose brain tumors. Rubenstein earned his medical degree at Weill Cornell Medicine and completed a residency in internal medicine at Stanford Medicine. He earned a doctorate in molecular and cellular neurosciences at the Rockefeller University. He completed a fellowship in hematology and oncology at UCSF, which included training in neuro-oncology. Rubenstein has won research awards from the Leukemia & Lymphoma Society and the National Cancer Institute. He is a member of the American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research. Dr. Rubenstein is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Primary Lymphoma of the Brain, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Vitrectomy. Dr. Rubenstein is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Rubenstein is currently accepting new patients.

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wolf is board certified in American Board Of Internal Medicine/Hematology, Hematology and American Board Of Internal Medicine, Internal Medicine. Dr. Wolf is currently accepting new patients.

Chainarong Limvarapuss is an Oncologist and a Hematologist Oncology provider practicing medicine in Vallejo, California. Dr. Limvarapuss is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Paget Disease of the Breast, Inflammatory Breast Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Limvarapuss is currently accepting new patients.

Ann Wexler is an Oncologist and a Hematologist Oncology provider practicing medicine in Vallejo, California. Dr. Wexler is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Colorectal Cancer. Dr. Wexler is currently accepting new patients.

Arun Rangaswami is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Rangaswami is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Hepatoblastoma, Fibrolamellar Carcinoma, Rhabdoid Tumor, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Lori Styles is a Hematologist and an Oncologist practicing medicine in Martinez, California. Dr. Styles is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Small Lymphocytic Lymphoma (SLL), and Sickle Cell Disease.

Katherine Matthay is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Matthay is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Ganglioneuroblastoma, and Bone Marrow Transplant.

Angela Rivers is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Rivers is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Anemia.

Caroline Hastings is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Hastings is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Niemann-Pick Disease, Non-Langerhans-Cell Histiocytosis, Reticulohistiocytoma, and Histiocytosis.

Eva Thomas is a Hematologist and an Oncologist practicing medicine in Richmond, California. Dr. Thomas is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. Dr. Thomas is currently accepting new patients.

Michael Bookman is an Oncologist and a Hematologist Oncology provider practicing medicine in San Francisco, California. Dr. Bookman is highly rated in 1 condition, according to our data. His clinical expertise encompasses Ovarian Cancer, Testicular Yolk Sac Tumor, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor. Dr. Bookman is currently accepting new patients.

Dr. Charalambos (Babis) Andreadis specializes in bone marrow transplantation for adults and in treating Hodgkin's and non-Hodgkin's lymphoma, leukemia and multiple myeloma. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. His research, published widely in scientific journals, examines genetic and other factors that affect how patients respond to therapy, including degrees of drug toxicity. He also studies patient outcomes in these disorders. Andreadis earned his medical degree at Columbia University's Vagelos College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha Honor Medical Society in 1998. He completed a residency at New York-Presbyterian Hospital and a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. He also earned a master's degree in clinical epidemiology at the University of Pennsylvania, focusing on pharmacogenetics, the study of how genes impact an individual's response to medications. Dr. Andreadis is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Andreadis is board certified in American Board Of Internal Medicine/Hematology, Hematology and American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Andreadis is currently accepting new patients.

A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Martin is board certified in American Board Of Internal Medicine, Hematology. Dr. Martin is currently accepting new patients.